Prime Medicine, Inc.PRMENASDAQ
Loading
Cash & Equivalents Over TimeContracting
Percentile Rank50
3Y CAGR-30.5%
5Y CAGR+11.3%
Year-over-Year Change
Cash on hand plus short-term liquid investments
3Y CAGR
-30.5%/yr
Annual compound
5Y CAGR
+11.3%/yr
Recent deceleration
Percentile
P50
Within normal range
vs 5Y Ago
1.7x
Solid growth
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $63.03M | -65.5% |
| 2024 | $182.48M | +338.9% |
| 2023 | $41.57M | -77.8% |
| 2022 | $187.62M | +1.2% |
| 2021 | $185.42M | +401.5% |
| 2020 | $36.98M | +327.6% |
| 2019 | $8.65M | - |